Unison Asset Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-32,967
Closed -$2.6M 35
2023
Q4
$2.6M Sell
32,967
-23,512
-42% -$1.67M 1.53% 22
2023
Q3
$3.94M Buy
56,479
+660
+1% +$46.8K 2.59% 18
2023
Q2
$3.86M Buy
55,819
+1,387
+3% +$98.7K 2.57% 20
2023
Q1
$4.04M Buy
54,432
+5,784
+12% +$485K 3.06% 16
2022
Q4
$4.53M Buy
48,648
+390
+0.8% +$37.6K 3.76% 14
2022
Q3
$4.6M Buy
48,258
+1,786
+4% +$177K 4.14% 11
2022
Q2
$4.31M Hold
46,472
4.2% 11
2022
Q1
$4.7M Hold
46,472
4.04% 12
2021
Q4
$4.79M Hold
46,472
3.95% 12
2021
Q3
$3.94M Sell
46,472
-133
-0.3% -$11.1K 3.51% 13
2021
Q2
$3.89M Sell
46,605
-4
-0% -$328 3.39% 14
2021
Q1
$3.51M Hold
46,609
3.24% 13
2020
Q4
$3.18M Buy
+46,609
New +$3.03M 3.16% 13

Other funds holding CVS

Unison Asset Management's CVS Position: Q1 2024 in Review

Unison Asset Management sold out of CVS Health (CVS) in Q1 2024, closing a stake of 32,967 shares — an estimated $2.6M sold.

Unison Asset Management first reported a position in CVS in Q4 2020 and held it in 13 quarters. The position peaked at $4.79M in Q4 2021. 2,177 funds tracked by Wall St. Rank hold CVS as of Q1 2024.

  • Unison Asset Management reported no remaining CVS Health position as of Q1 2024 after selling out during the quarter.
  • Unison Asset Management sold 32,967 CVS Health shares in Q1 2024, an estimated $2.6M.
  • Unison Asset Management first reported a position in CVS Health in Q4 2020 and held it in 13 quarters.
  • Unison Asset Management's CVS Health position peaked at $4.79M in Q4 2021.
  • 2,177 funds tracked by Wall St. Rank held CVS Health as of Q1 2024.

Based on Unison Asset Management's 13F filing for Q1 2024, filed 10 May 2024.